What's new

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Feb 27, 2025 - 14:29
 0
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Wolford: Annual revenue drops 30 percent

Next Article

B&G nears decision on potential sale of Green Giant frozen vegetables

Related Posts

Checklist for the submission of Type IA and Type IB (wi...

Feb 18, 2025  0

DARWIN EU data partners onboarded in phases I, II and III

Feb 20, 2025  0

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d] pyrimidin-6-yl)phenyl)methacrylamide hydrochloride Treatment of biliary tract cancer, 10/11/2022 Positive

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-met...

Feb 24, 2025  0